Australian Pancreatic Genome Initiative Lab

Returning individual research results for genome sequences of pancreatic cancer: Johns, A. L. ; Miller, D. K. ; Simpson, S. H. ; Gill, A. J. ; Kassahn, K. S. ; Humphris, J. L. ; Samra, J. S. ; Tucker, K. ; Andrews, L. ; Chang, D. K. ; Waddell, N. ; Pajic, M. ; Pearson, J. V. ; Grimmond, S. M. ; Biankin, A. V. ; Zeps, N.;; Genome Medicine 6(5):42, 2014

Defining the molecular pathology of pancreatic body and tail adenocarcinoma: Dreyer, S. B.; Jamieson, N. B.; Upstill-Goddard, R.; Bailey, P. J.; McKay, C. J.; Biankin, A. V.; Chang, D. K.; BRITISH JOURNAL OF SURGERY 105(2):e183-e191, 2018

Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?: Gupta, R.; O'Connell, R.; Haynes, A. M.; Stricker, P. D.; Barrett, W.; Turner, J. J.; Delprado, W.; Horvath, L. G.; Kench, J. G.;; BJU International 116(3):343-350, 2015

Integrated genomic characterization of pancreatic ductal adenocarcinoma: Cancer Genome Atlas Research Network.; CANCER CELL 32(2):185-203, 2017

Lost in translation: returning germline genetic results in genome-scale cancer research: Johns, A. L., McKay, S. H., Humphris, J. L., Pinese, M., Chantrill, L. A., Mead, R. S., Tucker, K., Andrews, L., Goodwin, A., Leonard, C., High, H. A., Nones, K., Patch, A. M., Merrett, N. D., Pavlakis, N., Kassahn, K. S., Samra, J. S., Miller, D. K., Chang, D. K., Pajic, M., Australian Pancreatic Cancer Genome, Initiative, Pearson, J. V., Grimmond, S. M., Waddell, N., Zeps, N., Gill, A. J., Biankin, A. V.; Genome Medicine 28(9):41, 2017

Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features: Gill, A. J.; Lim, G.; Cheung, V. K. Y.; Andrici, J.; Perry-Keene, J. L.; Paik, J.; Sioson, L.; Clarkson, A.; Sheen, A.; Luxford, C.; Elston, M. S.; Meyer-Rochow, G. Y.; Nano, M. T.; Kruijff, S.; Engelsman, A. F.; Sywak, M.; Sidhu, S. B.; Delbridge, L. W.; Robinson, B. G.; Marsh, D. J.; Toon, C. W.; Chou, A.; Clifton-Bligh, R. J.; American Journal Of Surgical Pathology 43(1):35-46, 2019

Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program: Dwarte, T.; McKay, S.; Johns, A.; Tucker, K.; Spigelman, A. D.; Williams, D.; Stoita, A.; Hereditary Cancer in Clinical Practice 17:30, 2019

MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity: Sharbeen, G.; Youkhana, J.; Mawson, A.; McCarroll, J.; Nunez, A.; Biankin, A.; Johns, A.; Goldstein, D.; Phillips, P.; Oncotarget 8(6):9216-9229, 2017

Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: A low threshold for ALK immunohistochemistry Is required: Pickett, J. L.; Chou, A.; Andrici, J. A.; Clarkson, A.; Sioson, L.; Sheen, A.; Reagh, J.; Najdawi, F.; Kim, Y.; Riley, D.; Maidens, J.; Nevell, D.; McIlroy, K.; Valmadre, S.; Gard, G.; Hogg, R.; Turchini, J.; Robertson, G.; Friedlander, M.; Gill, A. J.; American Journal Of Surgical Pathology 41(10):1433-1442, 2017

Whole-genome landscape of pancreatic neuroendocrine tumours: Scarpa, A.; Chang, D. K.; Nones, K.; Corbo, V.; Patch, A. M.; Bailey, P.; Lawlor, R. T.; Johns, A. L.; Miller, D. K.; Mafficini, A.; Rusev, B.; Scardoni, M.; Antonello, D.; Barbi, S.; Sikora, K. O.; Cingarlini, S.; Vicentini, C.; McKay, S.; Quinn, M. C.; Bruxner, T. J.; Christ, A. N.; Harliwong, I.; Idrisoglu, S.; McLean, S.; Nourse, C.; Nourbakhsh, E.; Wilson, P. J.; Anderson, M. J.; Fink, J. L.; Newell, F.; Waddell, N.; Holmes, O.; Kazakoff, S. H.; Leonard, C.; Wood, S.; Xu, Q.; Nagaraj, S. H.; Amato, E.; Dalai, I.; Bersani, S.; Cataldo, I.; Dei Tos, A. P.; Capelli, P.; Davi, M. V.; Landoni, L.; Malpaga, A.; Miotto, M.; Whitehall, V. L.; Leggett, B. A.; Harris, J. L.; Harris, J.; Jones, M. D.; Humphris, J.; Chantrill, L. A.; Chin, V.; Nagrial, A. M.; Pajic, M.; Scarlett, C. J.; Pinho, A.; Rooman, I.; Toon, C.; Wu, J.; Pinese, M.; Cowley, M.; Barbour, A.; Mawson, A.; Humphrey, E. S.; Colvin, E. K.; Chou, A.; Lovell, J. A.; Jamieson, N. B.; Duthie, F.; Gingras, M. C.; Fisher, W. E.; Dagg, R. A.; Lau, L. M.; Lee, M.; Pickett, H. A.; Reddel, R. R.; Samra, J. S.; Kench, J. G.; Merrett, N. D.; Epari, K.; Nguyen, N. Q.; Zeps, N.; Falconi, M.; Simbolo, M.; Butturini, G.; Van Buren, G.; Partelli, S.; Fassan, M.; Australian Pancreatic Cancer Genome, Initiative; Khanna, K. K.; Gill, A. J.; Wheeler, D. A.; Gibbs, R. A.; Musgrove, E. A.; Bassi, C.; Tortora, G.; Pederzoli, P., et al.; NATURE 543(7643):65-71, 2017

RAF1 rearrangements are common in pancreatic acinar cell carcinomas: Prall, O. W. J.; Nastevski, V.; Xu, H.; McEvoy, C. R. E.; Vissers, J. H. A.; Byrne, D. J.; Takano, E.; Yerneni, S.; Ellis, S.; Green, T.; Mitchell, C. A.; Murray, W. K.; Scott, C. L.; Grimmond, S. M.; Hofmann, O.; Papenfuss, A.; Kee, D.; Fellowes, A.; Brown, I. S.; Miller, G.; Kumarasinghe, M. P.; Perren, A.; Nahm, C. B.; Mittal, A.; Samra, J.; Ahadi, M.; Fox, S. B.; Chou, A.; Gill, A. J.; MODERN PATHOLOGY 33(9):1811-1821, 2020

Provenance and risk in transfer of biological materials: Nielsen, J.; Bubela, T.; Chalmers, D. R. C.; Johns, A.; Kahl, L.; Kamens, J.; Lawson, C.; Liddicoat, J.; McWhirter, R.; Monotti, A.; Scheibner, J.; Whitton, T.; Nicol, D.; PLOS BIOLOGY 16(8):e2006031, 2018

Expression of phosphorylated-mTOR during the development of prostate cancer: Sutherland, S. I. ; Pe Benito, R. ; Henshall, S. M. ; Horvath, L. G. ; Kench, J. G.;; PROSTATE 74(12):1231-9, 2014

Return of individual research results from genomic research: A systematic review of stakeholder perspectives: Vears, D. F.; Minion, J. T.; Roberts, S. J.; Cummings, J.; Machirori, M.; Blell, M.; Budin-Ljosne, I.; Cowley, L.; Dyke, S. O. M.; Gaff, C.; Green, R.; Hall, A.; Johns, A. L.; Knoppers, B. M.; Mulrine, S.; Patch, C.; Winkler, E.; Murtagh, M. J.; PLoS One 16(11):e0258646, 2021